- Home
- GSUN vs KLTO Comparison
GSUN vs KLTO Comparison
Compare GSUN & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSUN
- KLTO
- Stock Information
- Founded
- GSUN 1997
- KLTO 2019
- Country
- GSUN China
- KLTO United States
- Employees
- GSUN N/A
- KLTO N/A
- Industry
- GSUN Other Consumer Services
- KLTO
- Sector
- GSUN Real Estate
- KLTO
- Exchange
- GSUN Nasdaq
- KLTO NYSE
- Market Cap
- GSUN 6.4M
- KLTO 5.9M
- IPO Year
- GSUN 2022
- KLTO N/A
- Fundamental
- Price
- GSUN $2.38
- KLTO $0.71
- Analyst Decision
- GSUN
- KLTO
- Analyst Count
- GSUN 0
- KLTO 0
- Target Price
- GSUN N/A
- KLTO N/A
- AVG Volume (30 Days)
- GSUN 60.6K
- KLTO 84.5M
- Earning Date
- GSUN 08-01-2025
- KLTO 08-15-2025
- Dividend Yield
- GSUN N/A
- KLTO N/A
- EPS Growth
- GSUN N/A
- KLTO N/A
- EPS
- GSUN N/A
- KLTO N/A
- Revenue
- GSUN $10,159,020.00
- KLTO N/A
- Revenue This Year
- GSUN N/A
- KLTO N/A
- Revenue Next Year
- GSUN N/A
- KLTO N/A
- P/E Ratio
- GSUN N/A
- KLTO N/A
- Revenue Growth
- GSUN 65.04
- KLTO N/A
- 52 Week Low
- GSUN $2.23
- KLTO $0.11
- 52 Week High
- GSUN $8.94
- KLTO $3.91
- Technical
- Relative Strength Index (RSI)
- GSUN 26.08
- KLTO N/A
- Support Level
- GSUN $2.50
- KLTO N/A
- Resistance Level
- GSUN $2.88
- KLTO N/A
- Average True Range (ATR)
- GSUN 0.12
- KLTO 0.00
- MACD
- GSUN -0.07
- KLTO 0.00
- Stochastic Oscillator
- GSUN 15.43
- KLTO 0.00
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.